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Abstract
Background: MotherToBaby Utah is a teratogen information service that provides support for pregnant and
breastfeeding women and healthcare providers regarding risks of exposures to medications, infections, herbals,
homeopathic and dietary medications, chemicals and other substances. Calls are anonymous and free of charge.
This study was undertaken to examine the volume and classification of calls regarding exposures during pregnancy
and breastfeeding.
Methods: Data were extracted from calls requesting information about medication use and other exposures to
pregnant and breastfeeding women, between January 1 2009 and December 31 2012. Descriptive statistics were
calculated.
Results: A total of 27,299 calls regarding 46,031 exposures were identified in this study population. The majority of
calls were made by the exposed individual (82.1 %); 13.0 % were made by a healthcare provider and 4.9 % were
made by a family member or acquaintance. The majority of calls concerned pregnancy (65.8 %) versus
breastfeeding (34.2 %). Exposure during the current pregnancy was the subject of 88.6 % of calls. For calls where
trimester information was available, the percentage of calls for first, second and third trimesters were 44.1, 32.5 and
23.4 %, respectively.
Conclusion: This study found analgesics, cold medications, herbals, homeopathic, and dietary medications were of
the topic of concern for the majority of the calls regarding exposure during pregnancy and/or breastfeeding.
Teratogen information services gather and provide important educational resources for both patients and
healthcare providers. As the majority of calls concern nonprescription drugs and vaccines, these data provide
insight into a lack of education on these subjects that should be addressed during prenatal care.
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Background
Medications are commonly used during pregnancy and
breastfeeding. However, there is a scarcity of data in this
population published in the United States of America
(USA) regarding specific exposures and their prevalence.
While it has been reported that 77–96 % of pregnant
women are prescribed at least one medication during
their pregnancy [1–5], the majority of the available
literature focuses on prescription medications. Irvine et al.
[2], have reviewed the use of over-the counter antacids,
oral iron, and folic acid preparations, but those drugs were
not the focus of their overall study. One study has looked
to review frequently consumed herbal remedies during
pregnancy, both alone and concomitantly with prescribed
medications to assess side effects to the mother and fetus/
neonate. Generally, there is a lack of basic knowledge as
to the indications for use and safety of herbal medicines
used in pregnancy and breastfeeding, not only for preg-
nant woman, but also for clinicians.
MotherToBaby Utah is an affiliate of the national
MotherToBaby service of the Organization of Teratology
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Information Specialists (OTIS). The goal of Mother-
ToBaby/OTIS is to provide up-to-date and evidence-
based information to pregnant and breastfeeding
women, health care providers, and the general public
regarding risks or relative safety of medications and
other exposures during pregnancy and breastfeeding.
All calls made to MotherToBaby/OTIS are anonym-
ous, with more than 100,000 women and their health
care providers seeking information about birth defect
prevention every year.
There is a great need for more information regarding
the use of medications in pregnancy and breastfeeding [6].
It is well known that use of medications in pregnancy and
breastfeeding is widespread and medically necessary, but
there is little information about which medications or
exposures are the most common, especially in the United
States [7]. The purpose of this study was to expand the
current knowledge about the prevalence and classification
of medications or exposures in pregnant and women
breastfeeding in the United States.
Methods
A retrospective review of the MotherToBaby Utah database
was conducted for calls made to the MotherToBaby Utah
service between January 1 2009 and December 31 2012.
MotherToBaby Utah is an affiliate of MotherToBaby and is
based in Salt Lake City, Utah within the Utah Department
of Health [8]. Calls are taken Monday through Friday be-
tween business hours, 9–5 pm MST. Calls are also routed
from nine additional states (Colorado, Idaho, Minnesota,
Montana, Nevada, North Dakota, South Dakota, Virginia,
and Wyoming) across the United States as well as those
from within Utah. The study qualified as an expedited
review as designated by the University of Utah, Utah
Department of Health and IHC Internal Review Boards
(IRB). Data was obtained from a de-identified database,
and no consent was deemed necessary. No individual are
data presented herein.
Data were collected during each call using a standard-
ized questioning procedure throughout the call and a brief
survey taken at the end of each call. Data collected during
calls includes: caller identity (i.e., exposed individual,
health care provider, family member, etc.), gestational age
if pregnant, and age of infant if breastfeeding, whether the
subject’s potential exposure was during a current, pro-
spective, or retrospective pregnancy, and classification
(e.g. pharmaceutical, environmental, etc.) of possible ex-
posure. The counsellors ask about all potential exposures,
not just the substance of concern that the caller enquires
about. Important to note, the term “of highest concern”
was used for the substances with the highest number
of calls made to the center by regional callers. It spe-
cifically references the substances that were of highest
concern to the callers and does not indicate a ranking
by an organization. This designation was solely based
on the highest number of calls each substance received.
Lexicomp and the PDR (Physicians’ Desk Reference) were
used as the standard pharmaceutical references to code
the respective medicines categories.
All data collected from the calls were manually entered
into the MotherToBaby Utah database at the time of the
call. Data were then extracted into a separate Microsoft
Access® database for further analysis. Descriptive statistics
were performed in Excel® using this database; this in-
cluded determination of the frequency of calls under
each classification.
Results
Within the review timeframe 27,299 telephone calls were
made to MotherToBaby Utah (Table 1). The majority of
calls came from the potentially exposed individual
themselves (n = 22,404; 82.1 %); these were women
who are trying to conceive, pregnant, or breastfeed-
ing. This is in comparison with calls from health care
professionals (n = 3557; 13.0 %), or family members or
acquaintances (n = 1338; 4.9 %).
Eighty percent (n = 21,839; 80 %) of the callers were
inquiring whether a product, drug or medication was safe
before they used it and exposed the fetus/nursing baby;
thus making the potential for prevention more likely.
The overall majority of calls to MotherToBaby Utah
concerned exposures in pregnancy (total number and
percent of total; n = 14,806; 65.8 %) compared with
breastfeeding (n = 9345; 34.2 %). Of the calls regarding
pregnancy, 44.1 % (n = 6527) were in the first trimester,
32.5 % (n = 4814) were in the second trimester, and
23.4 % (n = 3465) were in the third trimester. Inquiries
about exposures in pregnancy were either for a current
pregnancy (n = 13,118; 88.6 %), planning for a future
pregnancy (n = 1303; 8.8 %), or an exposure during a
past pregnancy (n = 59; 0.4 %).
Exposures
There were a total of 46,031 possible potential exposures
recorded (Table 1) from the 27,299 total calls. Of these
exposures, 31,546 (68.5 %) were prescription and over-
the-counter (OTC) medications, 5597 (12.2 %) related to
immunizations, 4462 (9.7 %) were related to herbals,
homeopathic and dietary medications, 3935 (8.6 %) were
non-medications (includes health care items; e.g., tooth-
paste, bubble bath, and environmental chemicals), and
491 (1.1 %) were substances of abuse. There were a total
of 924 unique possible exposures. For calls classified as
environmental exposures, this included alcohol, however,
very few calls related to alcohol exposure. In addition,
the non-medications category included beauty products,
bug repellents, cigarettes/nicotine/tobacco/marijuana, hot
tubs/hot baths, solvents/paint.
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With regards to herbals, homeopathic, and dietary
medications, using the MotherToBaby database, dietary
medications are entered only by their category (i.e.,
herbs/dietary medications). This is a limitation of the
study and the MotherToBaby operation is in process of
correcting this. The risk statement for these exposures
provided to the caller is the same for most inquires on
herbs, homeopathic, and dietary medications: these prod-
ucts are not regulated by the FDA, therefore, exact
product ingredients are not known and difficult to know
whether or not the product is of concern. There is not
enough published data to determine whether these prod-
ucts are safe to use on a regular basis in pregnancy or
while breastfeeding.
The exposures for which advice was most frequently
sought were for the influenza vaccination (n = 3422; 7.4 %),
acetaminophen (n = 3085; 6.7 %), and pseudoephedrine
(n = 1836; 4.0 %).
Immunizations
Calls to MotherToBaby Utah concerning immunizations/
vaccinations totaled 5597. Of these calls, 68.9 % (n = 3854)
were related directly to a vaccination and 31.1 % (n = 1743)
were related to a vaccine-preventable disease (Table 2).
Inquiries regarding influenza and/or its vaccine (n = 5112)
made up 91.3 % of immunization-related inquiries and
11.1 % of the overall inquiries to MotherToBaby Utah.
There were 1619 callers who inquired specifically about the
H1N1 influenza vaccine. Vaccine-preventable disease in-
quiries by disease included: Anthrax n = 1; H1N1 n = 550;
Hepatitis A n = 37; Hepatitis B n = 62; Hib n = 1; Influenza
n = 4433; Measles, Mumps, Rubella n = 90; Meningococcal
n = 11; Pneumococcal n = 6; Polio n = 2; Rabies n = 2;
Shingles n = 1 Tdap n = 348; Typhoid n = 15; Varicella
n = 30; Yellow Fever n = 8. No calls were reported for
Japanese encephalitis, HPV or Small Pox Vaccines.
Herbals, homeopathic and dietary medications
With respect to herbals, homeopathic and dietary medica-
tions, there were a total of 4462 calls, with the major-
ity of these inquiries being unspecified (n = 492), this
was closely followed by inquires related to caffeine
consumption (n = 415), zinc (n = 246), and vitamin C
(n = 205) supplements. With regards to inquiries being
unspecific, the caller provided the name of the herbal
medication, but it was not entered into the database
under the individual herbal name, only the category
name. This is a limitation of the study. Inquiries con-
cerning supplements directly related to prenatal care
included questions with regards to prenatal vitamins
(n = 179), vitamin B6 (n = 176), and folic acid (n = 143).
Table 1 List of medications and frequency of calls
Medication Frequency Category % Total %
Analgesics 6327 100 13.75
Acetaminophen 3085 48.76 6.7
Opioid 1257 19.87 2.73
NSAID 1224 19.35 2.66
Other 761 12.03 1.66
Anti-Infectives 3498 100 7.6
Antibacterial 2008 57.4 4.36
Antifungal 704 20.13 1.53
Antiviral 601 17.18 1.31
Other 185 5.289 0.4
Cardiovascular medications 884 100 1.92
Anticoagulant 416 47.06 0.9
Antihypertensive 246 27.83 0.53
Cardiac 147 16.63 0.32
Lipid-lowering 36 4.07 0.078
Other 39 4.41 0.092
Cold medications 9865 100 21.44
Antihistamine 3671 37.21 7.98
Cough medications 2728 27.65 5.93
Decongestant 3466 35.13 7.53
Corticosteroidsa 1191 100 2.59
Gastrointestinal medications 2423 100 5.26
Antacid 847 34.96 1.84
Antiemetic 496 20.47 1.08
Antidiarrheal 423 17.46 0.92
Laxative 91 3.76 0.2
Other 566 23.36 1.23
Psychiatric medications 4175 100 9.07
Antidepressant 2150 51.5 4.67
Sedative/hypnotic 962 23.04 2.09
Antipsychotic 343 8.22 0.75
Mood stabilizer 337 8.07 0.73
Stimulant 215 5.15 0.47
Other 168 4.02 0.36
Other medications 3183 100 6.91
aExposure could be topical or ingested
Table 2 List of frequency of calls related to potential exposure
to non-medications




Immunizations 5597 100 12.16
Vaccine 3854 68.86 8.37
Vaccine-preventable disease 1743 31.14 3.79
Non-medications (health care items;
e.g., toothpaste, bubble bath,
environmental chemicals, etc.)
3935 100 8.55
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Environmental chemicals
Chemicals were entered under the name of the agent
the individual was exposed to (e.g., toothpaste would
not be entered, but fluoride, sorbitol and the other
ingredients described by the caller that were contained
in the toothpaste). If the individual agent was not in
the database a note would be included so that the
agent would be added later. There were few environ-
mental chemicals described in this dataset, and many
potential individual agents were therefore not listed
and is a limitation of the study.
Discussion
The study presented here found that analgesics, vacci-
nations, cold medications (decongestants, cough medica-
tions, and antihistamine), and herbals, homeopathic and
dietary medications were of most frequent concerns for
callers to the MotherToBaby Utah service. The majority
of inquiries were from the potentially-exposed individual,
who were currently pregnant rather than from those who
were breastfeeding. Most of the inquiries were related to
exposures during the first trimester of pregnancy.
With regards to the high proportion of calls relating to
medications obtained in the non-prescription setting,
including herbal/other natural health products/supple-
ments there have been few studies that have explored
the use of herbals, homeopathic and dietary medications
during pregnancy and breastfeeding. Herbal products
are regulated by the Food and Drug Administration
(FDA) as foods. Manufacturers are not required to do
the pre- and post-marketing surveillance to determine if
there is an increase in the risk of birth defects, other
negative pregnancy outcomes, or side-effects in breast-
fed babies. Due to limited information online and from
health care providers, many called the MotherToBe
service seeking advice about these exposures during
pregnancy and breastfeeding. With limited data on dose/
amount of the exposure, a true risk assessment was not
possible. Until the regulations regarding herbals and
other natural products change, and more evidence based
studies are undertaken, there are no known safe expo-
sures for these products during pregnancy and
breastfeeding.
Holden et al. [9], interestingly found no difference in
the rates of herbals and other natural product use be-
tween pregnant and non-pregnant users. Indicating that
use by pregnant women in the United States is common,
with over a third of the population using one or more
therapies. Of more concern, only half disclosed the use
of these types of substances to their providers. It appears
that use is increasingly commonplace and as outlined by
a recent study [10] in Australia. Pregnant women want
more personal control over their bodies and are more
concerned about their own personal experience when
taking a herbal medicine during pregnancy rather than
clinical evidence of efficacy. Many pregnant women are
turning also to Chinese medicine, but similar to conven-
tional pharmaceuticals, Chinese medicines are not free
of risk, and have the potential to cause adverse preg-
nancy outcomes and fetal development [11]. There is
limited clinical data concerning the safety of maternal
exposure to Chinese medicines and basic research and
mechanistic studies of the potential teratogenicity of
Chinese medicines are lacking [11]. Unfortunately, the
MotherToBaby Utah service does not categorize out
Chinese medicines as a separate classification, however,
this is to be considered in the future as the use of these
products increases.
A comparative study was undertaken by Patil et al. [12],
this was also a retrospective descriptive study of preg-
nancy and breastfeeding related inquiries to the University
of North Carolina Health Care System Drug Information
Center (January 2001 to December 2010). Their review of
433 calls found that inquiries were most often made
during the antepartum period (34 %), followed by the
postpartum (28 %) and preconception (22 %) periods. This
is in contrast to the majority (88.6 %) of inquiries to
MotherToBaby Utah which were made during a current
pregnancy. The study undertaken by Patil et al. [12], deter-
mined the most frequent indications for inquiries to their
service were related to psychiatry and infectious disease-
related medication use in pregnancy.
One reason for the difference in inquires between
MotherToBaby Utah could be that the North Carolina
Health Care System Drug Information Centre would
mostly respond to questions from health care providers
and not the public. Most teratogen information services
(TIS) take a larger percent of calls from the public and
exposure questions would therefore differ. Future pro-
jects would include data from all TIS’ in the United
States to determine regional medication usage of medi-
cations by pregnant and breastfeeding women. There is
other literature describing TIS call experiences, but not
from USA teratogen information services. The only
other relatively recent large analysis of an equivalent ser-
vice came out of Australia which showed there was a de-
mand for such a service especially in rural areas [13].
Medication use is common and prevalence of use
during pregnancy is increasing [14]. This study provides
counseling focal points for health care providers in preg-
nant and breastfeeding populations. The vast majority of
maternal medications have an undetermined risk for
birth defects or other adverse fetal outcomes because
they have not been adequately studied in human pregnancy
[15]. Many of the common exposures do not require a pre-
scription and are readily accessible, and make up the great-
est concern of those calling MotherToBaby Utah. There is
a need for increased efforts in educating the public,
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especially women who are currently or thinking of becom-
ing pregnant, of risks as well as the relative safety of com-
mon exposures. Although this study helps expand current
knowledge of common exposures in pregnancy and breast-
feeding in the USA, larger studies are needed. Prenatal care
should encompass up-to-date and appropriate education
regarding these common exposures in pregnant and breast-
feeding women.
Limitations
Overall, few studies have been published regarding medi-
cation use during pregnancy and breastfeeding. As callers
to the MotherToBaby Utah service may call more than
one time, prevalence could not be determined in these
data. Updates to the database would need to be completed
in order to determine prevalence. In addition, although it
is rare that a health care provider and the mother
would both call regarding the same exposure concern,
it could happened. Both inquires would then be re-
ported in the database. The current system does not
account for the number of times this might happen.
It is reasonable to view this as educating two separate
individuals, the health care provider and the mother.
Educating providers on common exposures in preg-
nant and breastfeeding women may reduce the need
for mothers and other concerned individuals to con-
tact the service.
In the MotherToBaby Utah system, vitamins are en-
tered separately and would be entered by the name of
the vitamin e.g., vitamin B6 is entered as Pyridoxine
and vitamin B9 would be entered under folic acid.
When searching the database, vitamins would not be
included in the results of the database under Herbs/
Dietary Supplements.
With regards to pregnant women taking OTCs, it is
possible that women using OTC medications are not
seeking professional advice and therefore could be more
likely to call MotherToBaby Utah. Unfortunately, this
study was not designed to collect data to support this
statement. Most of the callers get the MotherToBaby
contact information from their health care provider or
are told by the health care provider to call the service. It
is possible that woman using OTC medications are more
likely to call the service.
Another limitation of the study is that termination of
pregnancies were not considered in these statistics and it
is unknown whether exposures could have led to termi-
nations either accidentally or intentionally. A 1989 study
found that calls to a teratogen information service re-
duced the number of abortions [16]. A recent change for
the MotherToBaby Utah service was to ask any caller
who brings-up abortion if they are still considering abor-
tion after the counselling. The abortion discussion is
rare among the calls received and would take some time
to have enough data to be statically significant.
Conclusion
This study found analgesics, cold medications, herbals,
homeopathic and dietary medications were of the most
concern for the majority of the calls regarding exposure
during pregnancy and/or breastfeeding. Most inquiries
were regarding exposures in a current pregnancy vs. breast-
feeding, specifically during the first trimester of pregnancy.
This study provides focal points for public and patient edu-
cation in regards to common exposures among pregnant
and breastfeeding women. As the majority of calls concern
non-prescription drugs and vaccines, these data provide
insight into a lack of education for these exposures that
should have been addressed during prenatal care. Prenatal
care should encompass appropriate education and guidance
on these common exposures for pregnant and/or breast-
feeding women.
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